IIJIMA Hiroaki

講師
学位：博士（医学）

基本情報

所属

Undergraduate School of Medicine / Faculty of Medicine

詳細情報

研究キーワード

Head and Neck Surgery
Syphilis
Aviation Medical Examination
sexually transmitted diseases
AGE-RAGE
Infection
Molecular biology
Otorhinolaryngology
Head and neck cancer

研究分野

Life sciences Infectious disease Sexually Transmitted Diseases (STD)
Life sciences Molecular biology
Life sciences Tumor diagnostics and therapeutics
Life sciences Otorhinolaryngology

受賞

Tokai Medical Association Tokai Journal Best Paper Award A Study of Patients with Recurrent or Metastatic Head and Neck Cancer Treated with Pembrolizumab

論文

Tetanus mimicking post-radiotherapy dysphagia in a head and neck cancer survivor:A case report with institutional review.

Comparison of Quality of Life After Transoral Robotic and Transoral Videolaryngoscopic Surgeries for Head and Neck Cancer

Development of a novel prognostic assessment tool for recurrent respiratory papillomatosis.

Recurrent laryngeal nerve schwannoma adjacent to the thyroid: a case report.

A Rare Case of Hemangioma in the Thyroid: Clinical Presentation and Management Insights.

Posturographic Markers for Early-Stage Parkinson's Disease in Elderly Patients Presenting with Dizziness: A Case Series in an ENT Clinic.

ニボルマブ療法後救済化学療法を施行した頭頸部癌患者における肺臓炎リスク因子の検討

Nivolumabを投与した頭頸部扁平上皮癌患者における予後因子としての好酸球数変化

Evaluating Clinical Outcomes and Predictive Factors of Treatment Approaches in T1-3N3b Hypopharyngeal Carcinoma: Upfront Neck Dissection Versus Concurrent Chemoradiotherapy.

A Case of Ectopic Thyroid Cancer in the Abdominal Cavity.

Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective study.

書籍等出版物

JOHNS Vol. 35, No. 5 [Mastering Traumatic Injuries in Otolaryngology] Airway Burns

講演・口頭発表等

A study on the treatment outcomes of PCE therapy as induction chemotherapy in our department.
TOVS in Head and Neck Oncology: Present Advances and Future Directions
Prognostic factors for nivolumab therapy in recurrent metastatic squamous cell carcinoma of the head and neck
Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitors for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck3